Google
×
Aptose is advancing new therapeutics focused on well validated and novel drug targets on the leading edge of cancer research. The company's pipeline includes ...
People also ask
Investors · Overview · News & Events · Overview · Press Releases · IR Calendar · Company Info · Overview · Management Team · Presentations · Financial Info.
Find the latest institutional holdings data for Aptose Biosciences, Inc. Common Shares (APTO) including shareholders, ownership summaries, ...
2 days ago · Susan Pietropaolo - Managing Director-Corporate Communications & Investor Relations William Rice - Chairman, President & Chief Executive ...
Find the latest Aptose Biosciences Inc. (APTO) stock quote, history, news and other vital information to help you with your stock trading and investing.
The report will be for the fiscal Quarter ending Dec 2023. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast ...
Aptose Biosciences (APTO) Investor Presentation - Slideshow · SA TranscriptsThu, Apr. 14, 2022. Aptose Biosciences Inc. (APTO) CEO Dr. William G. Rice on Q4 ...
Missing: relations | Show results with:relations
Nov 9, 2023 · Aptose Biosciences Inc. (APTO) announces promising results for tuspetinib (TUS) in the treatment of relapsed/refractory AML, including a 48% ...
APTO | Complete Aptose Biosciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Unify your omnichannel experience and enterprise with Aptos' leading solutions. See why the world's top retailers trust Aptos ONE, POS, Merchandising and ...